JP2024503441A5 - - Google Patents
Info
- Publication number
- JP2024503441A5 JP2024503441A5 JP2023542581A JP2023542581A JP2024503441A5 JP 2024503441 A5 JP2024503441 A5 JP 2024503441A5 JP 2023542581 A JP2023542581 A JP 2023542581A JP 2023542581 A JP2023542581 A JP 2023542581A JP 2024503441 A5 JP2024503441 A5 JP 2024503441A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- optionally substituted
- cells
- subject
- saturated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163139732P | 2021-01-20 | 2021-01-20 | |
| US63/139,732 | 2021-01-20 | ||
| PCT/US2022/012954 WO2022159475A1 (en) | 2021-01-20 | 2022-01-19 | Nanomaterials comprising an ionizable lipid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024503441A JP2024503441A (ja) | 2024-01-25 |
| JP2024503441A5 true JP2024503441A5 (enExample) | 2025-01-28 |
Family
ID=82549746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023542581A Pending JP2024503441A (ja) | 2021-01-20 | 2022-01-19 | イオン化可能な脂質を含むナノ材料 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240115511A1 (enExample) |
| EP (1) | EP4281064A4 (enExample) |
| JP (1) | JP2024503441A (enExample) |
| CN (1) | CN116963729A (enExample) |
| AU (1) | AU2022210317A1 (enExample) |
| CA (1) | CA3203741A1 (enExample) |
| WO (1) | WO2022159475A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3145913A1 (en) | 2019-07-29 | 2021-02-04 | James Everett Dahlman | Nanomaterials containing constrained lipids and uses thereof |
| IL294318A (en) | 2020-01-09 | 2022-08-01 | Guide Therapeutics Llc | Nanomaterials |
| CZ310613B6 (cs) | 2020-09-23 | 2026-01-28 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Lipidoidy pro transfekci nukleových kyselin a jejich použití |
| EP4281080A4 (en) | 2021-01-20 | 2025-09-24 | Beam Therapeutics Inc | NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT |
| CN116761888A (zh) | 2021-01-20 | 2023-09-15 | 比姆医疗股份有限公司 | 纳米材料 |
| CZ310443B6 (cs) | 2021-07-19 | 2025-06-25 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití |
| EP4713016A2 (en) * | 2023-05-15 | 2026-03-25 | The Trustees of The University of Pennsylvania | Delivery vehicle for targeted delivery to cardiomyocytes |
| AU2024279278A1 (en) | 2023-05-31 | 2025-12-18 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025137084A2 (en) * | 2023-12-18 | 2025-06-26 | Lifemine Therapeutics, Inc. | Triester compounds and methods of use thereof |
| TW202543585A (zh) | 2024-03-08 | 2025-11-16 | 美商健臻公司 | 脂質奈米粒子 |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
| WO2026030375A2 (en) | 2024-07-30 | 2026-02-05 | Genzyme Corporation | Lipid nanoparticles and methods of manufacture and use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2550449B1 (fr) * | 1983-08-12 | 1986-01-31 | Commissariat Energie Atomique | Agents de relaxation specifiques d'organes ou de pathologies, utilisables pour modifier les contrastes en imagerie medicale par resonance magnetique nucleaire |
| EP2367545A1 (en) * | 2008-10-17 | 2011-09-28 | Université Libre de Bruxelles | Di-vanilloyl and tri-vanilloyl derivatives for use in anti-cancer therapy |
| CN107879960B (zh) * | 2013-03-08 | 2021-06-22 | 诺华股份有限公司 | 用于传递活性成分的脂质和脂质组合物 |
| BR112019025104A2 (pt) * | 2017-05-30 | 2020-06-23 | Glaxosmithkline Biologicals S.A. | Método de fabricar um sistema de entrega não viral, sistema de entrega não viral, e, composição |
| CN120682290A (zh) * | 2017-07-04 | 2025-09-23 | 尹图赛利有限公司 | 包含可裂解接头的化合物及其用途 |
| CN116761888A (zh) * | 2021-01-20 | 2023-09-15 | 比姆医疗股份有限公司 | 纳米材料 |
-
2022
- 2022-01-19 JP JP2023542581A patent/JP2024503441A/ja active Pending
- 2022-01-19 WO PCT/US2022/012954 patent/WO2022159475A1/en not_active Ceased
- 2022-01-19 AU AU2022210317A patent/AU2022210317A1/en active Pending
- 2022-01-19 EP EP22743092.3A patent/EP4281064A4/en active Pending
- 2022-01-19 CN CN202280009720.7A patent/CN116963729A/zh active Pending
- 2022-01-19 CA CA3203741A patent/CA3203741A1/en active Pending
-
2023
- 2023-07-12 US US18/220,867 patent/US20240115511A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024503441A5 (enExample) | ||
| JP2024505449A5 (enExample) | ||
| JP2024502948A5 (enExample) | ||
| JP2024508347A5 (enExample) | ||
| JP2024502954A5 (enExample) | ||
| JP7654724B2 (ja) | 治療剤の細胞内送達のための化合物および組成物 | |
| JP2025501731A5 (enExample) | ||
| JP2025500824A5 (enExample) | ||
| RU2175337C2 (ru) | Полинуклеотидные композиции | |
| CA3113436A1 (en) | Compounds and compositions for intracellular delivery of therapeutic agents | |
| CN119684140A (zh) | 纳米材料 | |
| EP3661563A1 (en) | Biomimetic nanomaterials and uses thereof | |
| WO2022168085A1 (en) | Lipids suitable for nucleic acid delivery | |
| KR20120046099A (ko) | 섬유화를 억제하고 섬유화 질병을 치료하는 방법 | |
| CN114380724A (zh) | 用于递送核酸的阳离子脂质化合物和组合物及用途 | |
| EP3448364A1 (en) | Targeting the innate immune system to induce long-term tolerance and to resolve macrophage accumulation in atherosclerosis | |
| JP2024503976A5 (enExample) | ||
| US6344576B1 (en) | Phospholipid-analogous compounds | |
| US8501680B2 (en) | Antagonists against interaction of PF4 and RANTES | |
| US8048915B2 (en) | Biologically active complex | |
| EP4603475A1 (en) | Amino lipid compound and lipid nanoparticle for delivering bioactive ingredient | |
| FR3110836A1 (fr) | Utilisation de NMN pour réduire l’immunodépression et l’immunosénescence | |
| JP2025540229A (ja) | 複数の第三級アミン構造を含むビスホスホリルアミド化合物、及びその組成物と使用 | |
| KR20240167649A (ko) | 아미노 지질 화합물, 이의 제조 방법, 이의 조성물 및 이의 용도 | |
| JP2025525597A (ja) | アミノ脂質化合物、その製造方法およびその利用 |